Castration by orchidectomy or treatment with agonists of receptors for gonadotropin-releasing hormone (GnRH), also known as luteinizing hormone-releasing hormone (LH-RH), has been the standard of care in advanced prostate cancer. This evidence concerns the gene GNRH1 and prostate carcinoma.